key: cord-0985879-ztjf4rnt
authors: Vintzileos, William S.; Muscat, Jolene; Hoffmann, Eva; Vo, Duc; John, Nicole S.; Vertichio, Rosanne; Vintzileos, Anthony M.
title: Screening all pregnant women admitted to Labor and Delivery for the virus responsible for COVID-19
date: 2020-04-26
journal: Am J Obstet Gynecol
DOI: 10.1016/j.ajog.2020.04.024
sha: 474c39da025d9c35ff2b6ae88a538c708b90c5c9
doc_id: 985879
cord_uid: ztjf4rnt

nan

The COVID-19 pandemic sharply escalated in the United States in March and April of 24 2020. General medical and obstetric guidelines for managing suspected or positive COVID-19 25 patients mostly rely on maternal symptoms or close proximity to positive contacts to trigger 26 testing and subsequently diagnose COVID-19. 1 However, it has become apparent that most 27 cases of COVID-19 are the result of dissemination of the virus from asymptomatic individuals. 2 28

Persons who may unknowingly spread COVID-19 are often young and healthy, which fits the 29 demographic of many obstetric patients. Since medical staff are urged to conserve limited 30 personal protective equipment (PPE) for suspected or confirmed cases, 3 this increases the risk 31 of COVID-19 transmission to front-line health care workers from asymptomatic carriers. 32

Similarly, it increases the risk of COVID-19 transmission from mother to her infant or to other 33 obstetrical patients on a shared antepartum or postpartum unit. We propose, therefore, that were African-American, and 13.0% were Asian/Indian. 79

Of the 161 patients tested, 32 (19.9%) were COVID-19 positive and of these 11 (34%) 80 were symptomatic and 21 (66%) were asymptomatic (Table 1) 

Coronavirus disease 2019 (COVID-19), Situation Report 73. World Health Organization

sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_2. Published

COVID-19: Strategies for Optimizing the Supply of PPE

Coronavirus (COVID-19) and Pregnancy: What Maternal-Fetal Medicine Subspecialists 155 Need to Know. Society for Maternal Fetal Medicine

Interim Guidance: Healthcare Professionals 2019-nCoV

Xpert® Xpress SARS-CoV-2 has received FDA Emergency Use Authorization

Universal screening for SARS-CoV-2 in women 164 admitted for delivery

Twenty percent (32/161) of women admitted to L&D tested positive for Covid-19 97 infection; more importantly, almost two-thirds (66%) of COVID-19 positive women were 98 asymptomatic. All 29 neonates from COVID-19 positive mothers were negative. 99Routine testing for COVID-19 on admission to L&D resulted in an overall increase in the 100 use of PPE in approximately 10% of the cases. This, however, focused the use of PPE on the 101 right patient encounters. 102The results of our study have several important clinical implications. This approach 103 ensures that SARS-CoV-2 positive mothers are accurately identified and triaged. Clinicians can 104 monitor for the development of symptoms while these patients are admitted and allocate 105 inpatient resources appropriately (chest imaging, supplemental oxygen, infectious disease 106 consults) if a mother's respiratory status changes secondary to COVID-19.